https://www.selleckchem.com/pr....oducts/-r-s--3-5-dhp
Levofloxacin is considered a key component of a multidrug-resistant tuberculosis (MDR-T regimen. However, there is considerable concern regarding the subtherapeutic concentrations of the currently used doses and the development of drug resistance. Therefore, this study aimed to describe the population pharmacokinetics (PPK) of oral levofloxacin in healthy volunteers and to evaluate the probability of target attainment (PTA) in an attempt to optimize the dosing regimens for MDR-TB therapy. Data of levofloxacin in healthy volunte
Like
Comment
Share
